Bio-Rad Laboratories

Yahoo Finance • 2 months ago

Bio-Rad Laboratories (BIO) is a Classic Ariel Stock: Ariel Fund

Ariel Investments, an investment management company, released its “Ariel Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here. Due to the economy's resilience and forecasters' expectations of a soft landing... Full story

Yahoo Finance • 4 months ago

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coinc... Full story

Yahoo Finance • 7 months ago

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

HERCULES, Calif., May 30, 2024--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Anette Engelhardt will join the company as... Full story

Yahoo Finance • 8 months ago

96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?

96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity? Ninety-six percent, or 480 out of the 500 companies comprising the S&P 500 index, are trading at lower market values compared to Wall Str... Full story

Yahoo Finance • 8 months ago

Bio-Rad Laboratories (NYSE:BIO shareholders incur further losses as stock declines 14% this week, taking three-year losses to 53%

Investing in stocks inevitably means buying into some companies that perform poorly. Long term Bio-Rad Laboratories, Inc. (NYSE:BIO) shareholders know that all too well, since the share price is down considerably over three years. So they... Full story

Yahoo Finance • last year

6 Stock Picks in Healthcare for 2024

After an abysmal year for healthcare stocks, Wall Street is upbeat on Cigna, Humana, Bristol Myers, and three others. Continue reading... Full story

Yahoo Finance • last year

Q3 2023 Bio Rad Laboratories Inc Earnings Call

Participants Andrew J. Last; Executive VP & COO; Bio-Rad Laboratories, Inc. Dara Grantham Wright; Executive VP & President of Clinical Diagnostics Group; Bio-Rad Laboratories, Inc. Ilan Daskal; Executive VP & CFO; Bio-Rad Laboratories,... Full story

Yahoo Finance • last year

Bio-Rad Laboratories Inc (BIO) Q3 2023 Earnings: A Detailed Review

Third-quarter 2023 total net sales decreased by 7.1% to $632.1 million compared to $680.8 million in Q3 2022. Net income for Q3 2023 was $106.3 million, a significant increase from a net loss of $162.8 million in the same period in 2022. L... Full story

Yahoo Finance • last year

Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)

Key Insights The projected fair value for Bio-Rad Laboratories is US$399 based on 2 Stage Free Cash Flow to Equity Current share price of US$385 suggests Bio-Rad Laboratories is potentially trading close to its fair value Our fair value e... Full story

Yahoo Finance • last year

Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference

HERCULES, Calif., August 28, 2023--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate... Full story

Yahoo Finance • last year

Wells Fargo Predicts up to 125% Rally for These 2 Stocks — Here’s Why They Have Solid Upside

Even accounting for recent losses, the tech-heavy NASDAQ index is up 28% so far this year, leading the way in an overall bullish market. The surge in the NASDAQ has been fueled by investors gravitating towards tech giants. According to Ch... Full story

Yahoo Finance • last year

10 Beaten Down Stocks Billionaires Are Loading Up On

In this piece, we will take a look at ten beaten down stocks billionaires are loading up on. If you want to skip our analysis of the current state of the American economy, then head on over to 5 Beaten Down Stocks Billionaires Are Loading... Full story

Yahoo Finance • 2 years ago

Bio-Rad Laboratories First Quarter 2023 Earnings: EPS: US$2.33 (vs US$112 loss in 1Q 2022)

Bio-Rad Laboratories (NYSE:BIO) First Quarter 2023 Results Key Financial Results Revenue: US$676.8m (down 3.3% from 1Q 2022). Net income: US$69.0m (up from US$3.37b loss in 1Q 2022). Profit margin: 10% (up from net loss in 1Q 2022). EPS:... Full story

Yahoo Finance • 2 years ago

Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios

Cytek Biosciences, Inc. New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems FREMONT, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Delivering a boost to immuno-oncology and immunotherapy researchers, Cytek Biosciences... Full story

Yahoo Finance • 2 years ago

Retirement Stock Portfolio: 11 Safe Healthcare Stocks to Consider

In this article, we discuss the 11 safe healthcare stocks for a retirement stock portfolio. If you want to read about some more healthcare stocks, go directly to Retirement Stock Portfolio: 5 Safe Healthcare Stocks to Consider. The health... Full story

Yahoo Finance • 2 years ago

15 Biggest Medical Device Companies in the World

In this article, we will take a look at the 15 biggest medical device companies in the world. If you want to skip our introduction to the industry, then take a look at 5 Biggest Medical Device Companies in the World. The medical device ma... Full story

Yahoo Finance • 2 years ago

Top 10 Healthcare Stocks to Buy

In this article, we discuss top 10 healthcare stocks to buy. If you want to read about some more healthcare stocks, go directly to Top 5 Healthcare Stocks to Buy. Focus in the healthcare sector has steadily been shifting away from the cor... Full story

Yahoo Finance • 2 years ago

Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely

A rumored matchup between Bio-Rad Laboratories and Qiagen is unlikely, an analyst said Tuesday as BIO stock fell for a second straight day. Continue reading... Full story

Yahoo Finance • 2 years ago

East Bay life sciences company reportedly in talks with Qiagen in $10 billion deal

The company was started in Berkeley in the early 1950s, growing to nearly 8,000 employees worldwide. Continue reading... Full story

Yahoo Finance • 2 years ago

Investors are Watching These 10 Biotech Stocks

In this article, we discuss the 10 biotech stocks that investors are watching. If you want to read about some more biotech stocks, go directly to Investors are Watching These 5 Biotech Stocks. The stock market plunge in the past few weeks... Full story